Kava
Clinically studied for anxiety with a nuanced safety profile — extract type matters significantly
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your physician before starting any supplement.
Reports of liver toxicity associated with kava are largely linked to concentrated ethanol or acetone extracts. Traditional aqueous (water-based) extracts — the form used in Pacific Island cultures for centuries and in the best clinical trials — have a significantly better safety record. Do not combine with alcohol or other liver-metabolized substances. People with liver conditions, or who drink alcohol regularly, should avoid kava entirely.
Kava (Piper methysticum) is a plant native to the Pacific Islands where it has been consumed ceremonially and socially for thousands of years. Its active compounds — kavalactones — act on GABA receptors, serotonin receptors, and voltage-gated calcium channels, producing anxiolytic and mild sedative effects without the addictive properties of benzodiazepines or the next-day grogginess of many sleep aids.
The clinical evidence for kava's anxiolytic effects is among the strongest of any herbal supplement. It has been studied specifically in generalized anxiety disorder through multiple randomized controlled trials, and the effect sizes are meaningful — not the marginal improvements typical of many herbal anxiety products.
The liver safety question deserves honest treatment. A wave of liver toxicity reports in the early 2000s led to market withdrawals in several countries. Subsequent analysis suggested most cases involved ethanol or acetone extracts at high doses, not the traditional aqueous preparation used in Pacific cultures. More recent clinical trials using aqueous extracts have not found significant hepatotoxicity. The distinction between extract types is not minor — it appears to be central to the safety question.
Anxiety Reduction
The most studied and best-supported use. Multiple RCTs show significant reductions in Hamilton Anxiety Scale scores for generalized anxiety disorder, with effect sizes described as substantial in some trials.
Sleep Quality
A multicenter RCT found kava extract (WS 1490, 200mg/day) significantly improved sleep quality in patients with anxiety-related sleep disturbances compared to placebo, over four weeks.
Mild Mood Lifting
The KADSS trial found significant improvements in Montgomery-Åsberg Depression Rating Scale scores alongside anxiety reduction — suggesting kava may have concurrent mood-elevating effects in anxious individuals.
Non-Addictive Calming
Unlike benzodiazepines, kavalactones don't bind to benzodiazepine receptors. Long-term traditional use has not been associated with the addiction and withdrawal issues seen with pharmaceutical anxiolytics.
- Choose aqueous (water-based) extracts over ethanol or acetone extracts — the liver safety data is significantly better
- Never combine with alcohol — both are processed by the liver, and the combination significantly increases hepatotoxicity risk
- Use root-only products — leaves and stems have different alkaloid profiles with less favorable safety data
- Consider liver enzyme monitoring if using long-term — a reasonable precaution even with aqueous extracts
The Kava Anxiety Depression Spectrum Study (KADSS) — a randomized, placebo-controlled, double-blind crossover trial of 60 adults with generalized anxiety — found that an aqueous kava extract at 250mg kavalactones/day produced highly significant anxiolytic and antidepressant effects vs. placebo (p<0.0001) with a substantial effect size (d=2.24). Critically, no serious adverse effects and no clinical hepatotoxicity were observed, addressing long-standing safety concerns about the extract type used.
How Kava Compares
| Ingredient | Best For | Key Difference |
|---|---|---|
| Kava | Acute Anxiety & Stress | Strongest clinical evidence for anxiety; requires careful extract selection for safety |
| Ashwagandha | Chronic Stress & Cortisol | Better for ongoing cortisol-driven stress; no liver safety concerns at standard doses |
| Valerian Root | Sleep & Mild Anxiety | Primarily sleep-focused; milder anxiolytic effect; better safety profile for long-term use |
Kava has the strongest acute anxiolytic effect of the herbal options — but ashwagandha is often preferred for long-term daily use due to a cleaner safety profile.
- Sarris J et al. (2009). The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract. Psychopharmacology.
- Pittler MH, Ernst E. (2003). Kava extract for treating anxiety. Cochrane Database of Systematic Reviews.
- Teschke R et al. (2011). Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. European Journal of Gastroenterology & Hepatology.
Evidence-based supplement recommendations from a former physical store owner. No hype. No BS. Just facts.
Download Free PDF